Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
My Watchlist
Top Indices
My Portfolio

Bausch Health Companies Inc. Common Stock (NY:BHC)

6.450 -0.020 (-0.31%)
Official Closing Price Updated: 7:00 PM EDT, Sep 30, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Bausch Health Companies Inc. Common Stock

< Previous 1 2 3 4 5 6 7 8 9
...
13 14 Next >
Bausch Health's Aesthetic Business, Solta Medical, Brings Non-Invasive Aesthetic Innovations to National TV
Via ACCESS Newswire
Bausch Health to Announce Third Quarter 2025 Results on October 29
Via ACCESS Newswire
Bausch Health's OraPharma Introduces "OraTalks," a New Podcast Bringing Bold Conversations to Dentistry
Via ACCESS Newswire
Bausch Health Completes Acquisition of DURECT Corporation, Expanding Late-stage Liver Disease Portfolio
Via ACCESS Newswire
Bausch Health's Aesthetic Business, Solta Medical, Surpasses Milestone of 5 Million Skin Tightening Treatments with Thermage(R) Non-Surgical System
Via ACCESS Newswire
Earnings Scheduled For July 30, 2025
 
Via Benzinga
Bausch Health Companies's Earnings Outlook
 
Via Benzinga
Earnings Scheduled For April 30, 2025
 
Via Benzinga
Bausch Health Announces Extension of DURECT Corporation Tender Offer to September 10, 2025
Via ACCESS Newswire
A Look Into Bausch Health Companies Inc's Price Over Earnings
 
Via Benzinga
Billionaire Investor Buys Google And This Gold Miner Stock
John Paulson's hedge fund discloses the purchase of 9,000 shares of Alphabet. 
Via Benzinga
Icahn Hedge Fund's Q2 Moves: Centuri Stake Soars, JetBlue Held, 2 Positions Exited
Carl Icahn's 13F shows concentrated equity book, with top 10 holdings making up 98.76%. Notable changes in non-house names like CTRI and IFF. 
Via Benzinga
Bausch Health Announces Increase in Shareholding by its Chairperson of the Board and Board Changes
Via ACCESS Newswire
12 Health Care Stocks Moving In Friday's Pre-Market Session
Via Benzinga
Bausch Health Announces 2025 Gastrointestinal Health Scholars Program Winners
Via ACCESS Newswire
Bausch Health Announces Second Quarter 2025 Results
Via ACCESS Newswire
Bausch Health Adds Late-Stage Ready Alcohol Liver Disease Drug Candidate In $63 Million DURECT Buyout
Bausch Health will acquire DURECT and larsucosterol, aiming for FDA approval of a first treatment for alcoholic hepatitis via Phase 3 trials. 
Via Benzinga
Bausch Health to Acquire DURECT Corporation, Strengthening Commitment to Developing Innovative Solutions for Patients with Liver Disease
Via ACCESS Newswire
Bausch Health to Reduce Debt by Approximately $900 Million Using Cash On Hand
Via ACCESS Newswire
Bausch Health Announces the Appointment of Two New Members to Its Board of Directors
Via ACCESS Newswire
Bausch Health Appoints New Chief Accounting Officer
Via ACCESS Newswire
Bausch Health's Gastroenterology Business, Salix Pharmaceuticals, Launches Fresh "I Wish I Knew" Campaign to Educate People About Xifaxan(R) (rifaximin) for Adults at Risk of Overt Hepatic Encephalopathy Recurrence
Via ACCESS Newswire
Bausch Health to Announce Second Quarter 2025 Results on July 30
Via ACCESS Newswire
GMS Posts Upbeat Earnings, Joins Coinbase Global, Genworth Financial, Sandisk And Other Big Stocks Moving Higher On Wednesday
 
Via Benzinga
Oklo, Quantum Computing And Transocean Are Among Top 10 Mid Cap Gainers Last Week (June 9-13): Are The Others In Your Portfolio?
Top mid-cap stocks gain, led by energy companies due to increased oil prices from Middle East conflict. Oklo, Bausch Health, Quantum Computing among top performers. 
Via Benzinga
The Smart Money Is Buying These 10 Stocks
 
Via Benzinga
Icahn Ramps Up Bets On Genes And Jets: Illumina Stake Jumps 450%, JetBlue Holding Grow 90%
Carl Icahn boosts holdings in Illumina and JetBlue, showing confidence in biotech and airlines. He also trims exposure to Southwest Gas Holdings. 
Via Benzinga
Bausch Health Announces 2025 Annual Meeting of Shareholder Results
Via ACCESS Newswire
Xifaxan(R) (rifaximin) Treatment Following Overt Hepatic Encephalopathy (OHE) Hospitalization Associated with Reduced Risk of 30-Day OHE Rehospitalization
Via ACCESS Newswire
Bausch Health Announces First Quarter 2025 Results
Via ACCESS Newswire
< Previous 1 2 3 4 5 6 7 8 9
...
13 14 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.